Vault-13

Paradigm Biocapital Advisors LP

NEW YORK, NY · CIK 1855655 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2021 · limited partnership

As an employer

$501.5m reported value +32.6% vs Q1 2022
23positions
77.7%in top 10
5 new 16 added 1 reduced 7 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 978,596 $53.8m10.73% 10.73% AddedShares held: Q3 2021 —, Q4 2021 386.0k, Q1 2022 831.7k, Q2 2022 978.6k +146.9k +146,868 17.7%
2 GLOBAL BLOOD THERAPEUTICS IN COM GBT GBT 1,445,566 $46.2m9.21% 9.21% AddedShares held: Q3 2021 —, Q4 2021 780.5k, Q1 2022 966.8k, Q2 2022 1.4m +478.7k +478,739 49.5%
3 MIRATI THERAPEUTICS INC COM MRTX MRTX 659,968 $44.3m8.83% 8.83% AddedShares held: Q3 2021 —, Q4 2021 260.1k, Q1 2022 98.4k, Q2 2022 660.0k +561.6k +561,585 570.8%
4 SIERRA ONCOLOGY INC COM NEW COM NEW 801,314 $44.1m8.79% 8.79% AddedShares held: Q3 2021 —, Q4 2021 474.9k, Q1 2022 771.3k, Q2 2022 801.3k +30.0k +30,000 3.9%
5 INCYTE CORP COM INCY INCY 556,043 $42.2m8.42% 8.42% AddedShares held: Q3 2021 —, Q4 2021 0, Q1 2022 234.4k, Q2 2022 556.0k +321.6k +321,624 137.2%
6 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 432,170 $40.2m8.01% 8.01% AddedShares held: Q3 2021 —, Q4 2021 218.2k, Q1 2022 321.6k, Q2 2022 432.2k +110.5k +110,549 34.4%
7 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 163,066 $38.4m7.66% 7.66% AddedShares held: Q3 2021 —, Q4 2021 0, Q1 2022 75.6k, Q2 2022 163.1k +87.4k +87,431 115.6%
8 ARGENX SE SPONSORED ADR ARGX ARGX 88,816 $33.7m6.71% 6.71% NewShares held: Q3 2021 —, Q4 2021 42.0k, Q1 2022 0, Q2 2022 88.8k
9 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 667,417 $24.9m4.97% 4.97% AddedShares held: Q3 2021 —, Q4 2021 134.2k, Q1 2022 499.2k, Q2 2022 667.4k +168.2k +168,227 33.7%
10 ARVINAS INC COM ARVN ARVN 517,406 $21.8m4.34% 4.34% AddedShares held: Q3 2021 —, Q4 2021 268.5k, Q1 2022 491.3k, Q2 2022 517.4k +26.1k +26,073 5.3%
11 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 1,048,516 $17.6m3.51% 3.51% NewShares held: Q3 2021 —, Q4 2021 0, Q1 2022 0, Q2 2022 1.0m
12 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 876,156 $16.9m3.36% 3.36% AddedShares held: Q3 2021 —, Q4 2021 453.1k, Q1 2022 701.4k, Q2 2022 876.2k +174.8k +174,800 24.9%
13 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,306,569 $15.1m3.01% 3.01% AddedShares held: Q3 2021 —, Q4 2021 1.2m, Q1 2022 1.3m, Q2 2022 1.3m +50.5k +50,518 4.0%
14 MERUS N V COM MRUS MRUS 452,244 $10.2m2.04% 2.04% AddedShares held: Q3 2021 —, Q4 2021 0, Q1 2022 249.7k, Q2 2022 452.2k +202.5k +202,506 81.1%
15 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 1,408,050 $9.0m1.79% 1.79% AddedShares held: Q3 2021 —, Q4 2021 839.3k, Q1 2022 1.2m, Q2 2022 1.4m +250.8k +250,804 21.7%
16 TG THERAPEUTICS INC COM TGTX TGTX 1,964,709 $8.3m1.66% 1.66% NewShares held: Q3 2021 —, Q4 2021 0, Q1 2022 0, Q2 2022 2.0m
17 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 826,779 $7.0m1.40% 1.40% AddedShares held: Q3 2021 —, Q4 2021 0, Q1 2022 336.2k, Q2 2022 826.8k +490.6k +490,550 145.9%
18 ENANTA PHARMACEUTICALS INC COM ENTA ENTA 148,216 $7.0m1.40% 1.40% NewShares held: Q3 2021 —, Q4 2021 75.5k, Q1 2022 0, Q2 2022 148.2k
19 VOR BIOPHARMA INC COM COM 1,304,300 $6.5m1.29% 1.29% AddedShares held: Q3 2021 —, Q4 2021 629.3k, Q1 2022 894.4k, Q2 2022 1.3m +409.9k +409,896 45.8%
20 OYSTER PT PHARMA INC COM OYST OYST 1,333,330 $5.8m1.15% 1.15% AddedShares held: Q3 2021 —, Q4 2021 304.2k, Q1 2022 987.7k, Q2 2022 1.3m +345.6k +345,632 35.0%
21 GRACELL BIOTECHNOLOGIES INC SPONSORED ADS SPONSORED ADS 783,445 $4.3m0.86% 0.86% UnchangedShares held: Q3 2021 —, Q4 2021 545.4k, Q1 2022 783.4k, Q2 2022 783.4k
22 LIQUIDIA CORPORATION COM NEW LQDA LQDA 850,961 $3.7m0.74% 0.74% NewShares held: Q3 2021 —, Q4 2021 0, Q1 2022 0, Q2 2022 851.0k
23 C4 THERAPEUTICS INC COM STK CCCC CCCC 73,149 $552.0k0.11% 0.11% ReducedShares held: Q3 2021 —, Q4 2021 258.7k, Q1 2022 499.5k, Q2 2022 73.1k -426.3k -426,347 -85.4%

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
IVERIC BIO INC OPHT OPHT 910,416 $15.3m910.4k shares
IOVANCE BIOTHERAPEUTICS INC IOVA IOVA 907,428 $15.1m907.4k shares
HORIZON THERAPEUTICS PUB L HZNP HZNP 136,243 $14.3m136.2k shares
ZENTALIS PHARMACEUTICALS INC ZNTL ZNTL 287,577 $13.3m287.6k shares
PROTHENA CORP PLC PRTA PRTA 267,946 $9.8m267.9k shares
KYMERA THERAPEUTICS INC KYMR KYMR 227,034 $9.6m227.0k shares
FULCRUM THERAPEUTICS INC FULC FULC 212,961 $5.0m213.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
OLEMA PHARMACEUTICALS INC OLMA · 13G · filed 2025-02-14 OLMA 10.0%≈ $92.9m 13G 2025-02-14
EDGEWISE THERAPEUTICS INC EWTX · 13G · filed 2026-08-14 EWTX 9.5%≈ $415.1m +3.3 pts 13G 2026-08-14
ACHIEVE LIFE SCIENCES INC ACHV · 13G · filed 2026-04-24 ACHV 9.2%≈ $64.7m new 13G 2026-04-24
ASSEMBLY BIOSCIENCES INC ASMB · 13G · filed 2026-08-14 ASMB 7.8%≈ $42.7m +2.4 pts 13G 2026-08-14
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-08-14 VRDN 6.1%≈ $123.5m +1.0 pts 13G 2026-08-14
TYRA BIOSCIENCES INC TYRA · 13G · filed 2026-09-17 TYRA 5.8%≈ $110.9m new 13G 2026-09-17
LEXEO THERAPEUTICS INC LXEO · 13G · filed 2026-08-14 LXEO 5.3%≈ $19.4m -3.0 pts 13G 2026-08-14
MBX BIOSCIENCES INC MBX · 13G · filed 2026-06-24 MBX 5.2%≈ $137.6m new 13G 2026-06-24
SPYRE THERAPEUTICS INC SYRE · 13G · filed 2026-10-01 SYRE 5.1%≈ $395.7m new 13G 2026-10-01
JADE BIOSCIENCES INC JBIO · 13G · filed 2026-07-17 JBIO 5.1%≈ $69.0m new 13G 2026-07-17